Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Silver Shell is an antimicrobial material technology developed by Chitosan Health LLC, consisting of a patented silver-chitosan platform designed for application as surface coatings or embedded materials in textiles and medical devices. The technology utilizes silver chloride chitosan particles (larger than 100nm) integrated with chitosan to provide antimicrobial protection through both contact-based and silver ion-mediated mechanisms. Developed with NIH NIAID funding, the Advanced Silver Shell formulation uses significantly less silver than conventional antimicrobial finishes while maintaining high efficacy against healthcare-associated pathogens, including methicillin-resistant *Staphylococcus aureus* (MRSA), *Clostridioides difficile*, *Candida auris*, and *Pseudomonas aeruginosa*. It is intended to prevent surface contamination and healthcare-associated infections (HAIs) and has demonstrated durability through 75 washes in textile applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Silver Shell.